Microdose Medication ™
Pioneering targeted treatments for neurodegenerative and psychiatric disorders with advanced psychedelic drug delivery technology.
Pioneering targeted treatments for neurodegenerative and psychiatric disorders with advanced psychedelic drug delivery technology.
Microdose Medication ™ is a pioneering startup focusing on the development of psychedelic-based medications. Their nanotechnology-driven approach aims to create advanced treatments targeting severe neurodegenerative diseases and emerging psychiatric disorders. The company, founded in 2022 and based in the United Kingdom, holds a patent-pending technology for psychedelic drug delivery in clinical settings. With a mission to revolutionize treatment in the health care and pharmaceutical industries, Microdose Medication™ is a compelling force in the evolving landscape of medical innovation.
There is no investment information
No recent news or press coverage available for Microdose Medication ™.
We care about your data, and we'd love to use cookies make your experience better.